E0 ConsensusWeak / uncertainPEM not requiredSystematic-ReviewPeer-reviewedMachine draft
Standard · 3 min
Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies.
Davidson, Jonathan R T, Crawford, Cindy, Ives, John A et al. · The Journal of clinical psychiatry · 2011 · DOI
Quick Summary
This review looked at 25 studies testing whether homeopathic treatments help with psychiatric conditions like anxiety, depression, and sleep problems. The researchers found some evidence that homeopathy might help with chronic fatigue syndrome and fibromyalgia, but it did not help with anxiety or stress. Overall, the quality of the studies was mixed, and more research is needed to draw firm conclusions.
Why It Matters
This review is relevant to ME/CFS patients because it specifically examined homeopathic treatments for chronic fatigue syndrome alongside fibromyalgia and other functional somatic syndromes, identifying some evidence of potential benefit for this group. Understanding all available treatment evidence—including complementary approaches—helps ME/CFS patients and clinicians make informed decisions about symptom management options.
Observed Findings
Twenty-five eligible studies were identified from 1,431 initial records, with quality ratings of 6 good, 9 fair, and 10 poor according to SIGN 50 criteria.
Efficacy signals were observed in the functional somatic syndromes group, specifically fibromyalgia and chronic fatigue syndrome.
No statistically significant effect was found for homeopathy in anxiety or stress disorders.
Effect sizes were calculable in 16 studies and number-needed-to-treat in 10 studies.
No placebo-controlled randomized trials of homeopathy for depression were identified in the literature.
Inferred Conclusions
The authors concluded that homeopathy may have benefit for functional somatic syndromes including chronic fatigue syndrome and fibromyalgia, distinguishing this from psychiatric conditions.
They inferred that the overall evidence base is very limited and heterogeneous, preventing strong conclusions about efficacy in most psychiatric domains.
They noted that results do not preclude the possibility of some benefit despite methodological limitations across studies.
They suggested that tolerability appears good based on available safety reporting, though data were inadequate.
Remaining Questions
Why do functional somatic syndromes (fibromyalgia, chronic fatigue syndrome) show potential efficacy while anxiety disorders do not? Are the mechanisms different?
What This Study Does Not Prove
This review does not prove that homeopathy is an effective treatment for ME/CFS, only that the limited available evidence does not rule it out. The mixed quality of included studies, publication bias concerns, and lack of mechanistic explanation mean that any apparent benefit could be due to placebo effect or study design flaws rather than active treatment. Individual studies with small sample sizes cannot establish clinical efficacy as a standard treatment.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What are the active components or mechanisms by which homeopathy might benefit chronic fatigue syndrome, given the extreme dilutions used?
Why are there no published placebo-controlled trials of homeopathy for depression, and should this be a future research priority?
How would larger, higher-quality trials need to be designed to definitively establish whether observed effects are genuine or attributable to placebo response?